Mark Chang

1.2k total citations
11 papers, 166 citations indexed

About

Mark Chang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mark Chang has authored 11 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Mark Chang's work include Peripheral Artery Disease Management (3 papers), Renal cell carcinoma treatment (2 papers) and Cerebrovascular and Carotid Artery Diseases (2 papers). Mark Chang is often cited by papers focused on Peripheral Artery Disease Management (3 papers), Renal cell carcinoma treatment (2 papers) and Cerebrovascular and Carotid Artery Diseases (2 papers). Mark Chang collaborates with scholars based in United States. Mark Chang's co-authors include Sam N. Chawla, Sivaprasad Sukavaneshvar, Chi‐Ying Lee, Lan Cao, David G. Castner, Buddy D. Ratner, Thomas A. Horbett, Demetrius H. Bagley, Sumanta K. Pal and Robert A. Figlin and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The Journal of Urology.

In The Last Decade

Mark Chang

10 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Chang United States 6 84 44 40 31 30 11 166
Isabelle Talon France 9 65 0.8× 24 0.5× 9 0.2× 132 4.3× 30 1.0× 24 220
Binge Chang China 9 83 1.0× 4 0.1× 7 0.2× 13 0.4× 36 1.2× 13 226
Tiantian Chen China 8 28 0.3× 4 0.1× 5 0.1× 106 3.4× 38 1.3× 23 271
Christopher D. Derby United States 10 167 2.0× 7 0.2× 17 0.4× 173 5.6× 52 1.7× 20 349
Caitlin T. Demarest United States 9 39 0.5× 40 0.9× 3 0.1× 83 2.7× 85 2.8× 26 241
D Cristian Romania 8 52 0.6× 5 0.1× 2 0.1× 109 3.5× 16 0.5× 60 213
Matthew Zeiderman United States 9 31 0.4× 4 0.1× 4 0.1× 135 4.4× 101 3.4× 26 308
Sivakumar Sivalingam Malaysia 10 70 0.8× 5 0.1× 3 0.1× 98 3.2× 51 1.7× 54 271
Yuqin Cao China 9 104 1.2× 2 0.0× 12 0.3× 110 3.5× 14 0.5× 29 245

Countries citing papers authored by Mark Chang

Since Specialization
Citations

This map shows the geographic impact of Mark Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chang more than expected).

Fields of papers citing papers by Mark Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chang. The network helps show where Mark Chang may publish in the future.

Co-authorship network of co-authors of Mark Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Chang. A scholar is included among the top collaborators of Mark Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Chang. Mark Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chang, Mark, et al.. (2023). Utility of a nitinol stone extractor for intraocular foreign body removal. American Journal of Ophthalmology Case Reports. 32. 101917–101917. 2 indexed citations
3.
Pal, Sumanta K., Nora Ruel, Mark Chang, et al.. (2014). CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. PLoS ONE. 9(4). e94471–e94471. 6 indexed citations
4.
Pal, Sumanta K., et al.. (2014). Programmed death-1 inhibition in renal cell carcinoma: clinical insights and future directions.. PubMed. 12(2). 90–9. 14 indexed citations
5.
Pal, Sumanta K., Nora Ruel, Nicholas J. Vogelzang, et al.. (2013). Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease. Clinical Genitourinary Cancer. 12(3). 149–154. 4 indexed citations
6.
Chawla, Sam N., et al.. (2008). Effectiveness of High-Frequency Holmium:YAG Laser Stone Fragmentation: The “Popcorn Effect”. Journal of Endourology. 22(4). 645–650. 52 indexed citations
7.
Chang, Mark, et al.. (2008). LAPAROSCOPIC TRANSPERITONEAL RESECTION OF EXTRA- ADRENAL PHEOCHROMOCYTOMA OF THE ORGAN OF ZUCKERKANDL IN A PEDIATRIC PATIENT. The Journal of Urology. 179(4S). 303–303. 2 indexed citations
8.
Cao, Lan, Mark Chang, Chi‐Ying Lee, et al.. (2007). Plasma‐deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition. Journal of Biomedical Materials Research Part A. 81A(4). 827–837. 67 indexed citations
9.
Glassman, Deborah T., Leonard G. Gomella, Stephen E. Strup, et al.. (2006). Outcomes of hand-assisted laparoscopic nephrectomy in technically challenging cases. Urology. 67(1). 45–49. 10 indexed citations
10.
Dougherty, Matthew J., et al.. (2001). Abnormal Duplex Findings at the Proximal Anastomosis of Infrainguinal Bypass Grafts: Does Revision Enhance Patency?. Annals of Vascular Surgery. 15(1). 98–103. 5 indexed citations
11.
Dougherty, Matthew J., et al.. (2001). Abnormal duplex findings at the proximal anastomosis of infrainguinal bypass grafts: Does revision enhance patency?. Annals of Vascular Surgery. 15(1). 98–103. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026